Searchable abstracts of presentations at key conferences in endocrinology

ea0082wd15 | Workshop D: Disorders of the adrenal gland | SFEEU2022

ACTH secreting Pancreatic NET - an unusual presentation – A Case report

Nagarajah Kalyani

Neuroendocrine tumours are heterogenous group of diseases that can originate from any part of the gastrointestinal tract, bronchi, Thyroid and Pancreas. Tumours that arise from the endocrine Pancreas, on the islet of Pancreas, are called Pancreatic NET. Pancreatic NETs have an incidence of < 0.1 % per one million person and can lead to secretion of ectopic ACTH (1). Ectopic ACTH secretion accounts for 5-10 % of all patients presenting with ACTH dependent hypercortisolism: ...

ea0090p553 | Adrenal and Cardiovascular Endocrinology | ECE2023

Cushingoid features in a patient with adrenal insufficiency secondary to combined inhaled steroid and Itraconazole therapy

Nagarajah Kalyani , George Lindsay , Lansdown Andrew

Background: Iatrogenic adrenal insufficiency (AI) refers to primary, secondary, or tertiary hypoadrenalism associated with drug administration, surgery, or irradiation. The most common cause of secondary adrenal insufficiency is exogenous glucocorticoids. Hepatic metabolism of inhaled corticosteroids (ICS) takes place via cytochrome P450 3A4. Nevertheless, it can be decreased by enzyme inhibitors such as itraconazole or ritonavir, thus leading to an increase in the bioavailabi...

ea0090p97 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Bruns-Garland syndrome (diabetic amyotrophy) associated with SGLT2 inhibitor and its rapid HbA1c improvement: a case-report

Nagarajah kalyani , Panagiotou Grigorios , Karen Platts Julia

Background: Bruns Garlands syndrome is a rare disorder in people living with diabetes, manifesting as unilateral or bilateral muscle pain, weakness and atrophy in the proximal region of the lower limbs. Herein, we present the case of a patient with Bruns-Garland syndrome caused by sodium/glucose co-transporter 2 inhibitors (SGLT2i).Case description: A 55-year-old male with background of type 2 diabetes for 5 years, and currently on oral therapy, presente...

ea0091oc8 | Oral Communications | SFEEU2023

Bruns-Garland syndrome (diabetic amyotrophy) associated with SGLT2 inhibitor and its rapid HbA1c improvement: a case-report

Nagarajah Kalyani , Panagiotou Grigorios , Platts Julia

Background: Bruns Garlands syndrome is a rare disorder in people living with diabetes, manifesting as unilateral or bilateral muscle pain, weakness and atrophy in the proximal region of the lower limbs. Herein, we present the case of a patient with Bruns-Garland syndrome caused by sodium/glucose co-transporter 2 inhibitors (SGLT2i).Case description: A 55-year-old male with background of type 2 diabetes for 5 years, and currently on oral therapy, presente...

ea0090p499 | Thyroid | ECE2023

Radioiodine therapy outcomes in benign thyroid disease at the University Hospital of Wales, UK

Nagarajah Kalyani , Jones Elizabeth , Witczak Justyna , Taylor Peter , Lansdown Andrew

Background: Radioiodine therapy (I-131) is commonly prescribed for benign thyroid disease in keeping with recommended guidelines.Aims: To determine the effectiveness of I-131 in treating benign thyroid disease and the rates of hypothyroidism following treatment and by diagnosis.Methods: We identified 100 patients who received radioiodine therapy between November 2013 and June 2015 from a database held in the Medical Physics Departm...

ea0090p528 | Thyroid | ECE2023

A case of Kikuchi-Fujimoto disease with fluctuating thyroid autoantibodies

Nagarajah Kalyani , Lei Yin Win , Lansdown Andrew , Witczak Justyna

Introduction: Kikuchi-Fujimoto disease (KFD) is a benign self-limiting disease presenting with fever and lymphadenitis and mostly affecting adults younger than 40 years of age and of Asian descent. Its aetiology and pathogenesis are unknown though KFD often occurs in patients with concomitant autoimmune illness such as autoimmune thyroiditis or lupus erythematosus (SLE). We report a case of a patient with KFD and fluctuating thyroid function and thyroid autoantibody levels.</p...

ea0094p195 | Bone and Calcium | SFEBES2023

A case of Severe hypercalcemia secondary to Milk-Alkali syndrome:

Nagarajah Kalyani , Panagiotou Grigorios , George Lindsay , Evans Marc

Milk – alkali syndrome is a rare and distinctive disorder caused by ingestion of large amounts of calcium and absorbable alkali resulting in hypercalcemia. It is characterized by a triad of hypercalcemia, metabolic alkalosis and renal failure. Here we present a 59 years old female patient, who presented to Emergency department for a fall and Syncopal episode. She had a few days history of increasing thirst, polyuria and diffuse abdominal discomfort. This prior to her sync...